Panacea Biotec announced that Mukul Gupta (DIN: 00254597), Independent Director of the Company has completed his second and final term of 5 (five) consecutive years as Independent Director on 31 March 2026 and accordingly he has ceased to be an Independent director of the Company.

Net profit of Panacea Biotec declined 11.95% to Rs 3.98 crore in the quarter ended December 2025 as against Rs 4.52 crore during the previous quarter ended December 2024. Sales rose 1.04% to Rs 165.19 crore in the quarter ended December 2025 as against Rs 163.49 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales165.19163.49 1 OPM %7.114.87 - PBDT12.1710.59 15 PBT3.721.61 131 NP3.984.52 -12 Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net loss of Panacea Biotec reported to Rs 13.92 crore in the quarter ended September 2025 as against net profit of Rs 4.80 crore during the previous quarter ended September 2024. Sales declined 4.22% to Rs 141.13 crore in the quarter ended September 2025 as against Rs 147.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales141.13147.35 -4 OPM %-12.614.75 - PBDT-13.5310.67 PL PBT-21.871.99 PL NP-13.924.80 PL Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News